Channel Bio

Kentland, United States Founded: 2009 • Age: 17 yrs Acquired By Monsanto
Production and direct marketing of seeds for field crops including corn, soy, sorghum and alfalfa

About Channel Bio

Channel Bio is a Healthcare company based in Kentland (United States) founded in 2009, and was acquired by Monsanto in November 2004. Production and direct marketing of seeds for field crops including corn, soy, sorghum and alfalfa. It operates in the Healthcare and Agriculture sectors. Channel Bio offers products and services including Corn Seed, Soybean Seed, and Agronomy Tools. Its focus areas include Food and Agriculture Tech, Crop Tech, Farm Inputs and Seeds. Its competitors include Benson Hill, Cibus and Pairwise; 3 of its 3 listed competitors have raised funding.

Company details

Channel Bio Corp. is a fully owned subsidiary of the Monsanto Co which acquired it in Nov, 2004. It engages in field trials for new seed genetics, commercial production and marketing of genetically modified (GM) field crops including corn, soy, sorghum and alfalfa. Focuses on traits for improving yield and increasing tolerance to abiotic stresses. Has research partnerships with Monsanto for acquiring crop traits. The company has a network of sales agents who directly sell to the farmer; also sells through conventional resellers. It also provides seedsman services for identifying genetics suitable to farmers existing infrastructure and operations.

Key Metrics

Products & Services of Channel Bio

Channel Bio offers a comprehensive portfolio of products and services, including Corn Seed, Soybean Seed, and Agronomy Tools.

Corn Seed
Seed Products

High-quality seeds for efficient corn cultivation

Soybean Seed
Seed Products

Seeds designed for improved soybean yield and growth

Agronomy Tools
Digital Services

Resources for post-harvest management and crop advice

Apps and channels of Channel Bio

its YouTube channel Bayer United States has 97.5K subscribers and 30 videos.

Bayer United States
YouTube 97.5K subscribers 30 videos Science & Technology
Open channel

Videos from Channel Bio

The most watched videos on Channel Bio's YouTube channel, Bayer United States (97.5K subscribers). Click a video to play it here.

Luke Bryan - Take Care, Now (Nutrition) 2024
401.5K views
Luke Bryan - Take Care, Now (Energy) 2024
245.4K views
What is Glyphosate?
4K views
How We’re Taking Action to Tackle Tar Spot
2.7K views

More on Bayer United States.

Investors in Channel Bio

Channel Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Monsanto.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Genetically modified seeds and biotechnology traits are developed for farmers.
1901monsanto.comSt. Louis, United States
Premium access

Investor details for Channel Bio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Channel Bio

2 dated milestones of Channel Bio across 5 years, from founding to its latest funding, stage changes and deals.

  1. Exit Acquired by Monsanto.
  2. Founded Channel Bio is founded.

Competitors of Channel Bio

Channel Bio has 3 listed competitors in our database, 3 of them funded. They include Benson Hill, Cibus and Pairwise.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bensonhill.com2012St. Louis, United States$406.99M151
Provider of plant-based food ingredients
cibus.com2001San Diego, United States$34.47M129
Gene editing solutions are provided for agriculture.
pairwise.com2017Durham, United States$155M
New crop varieties are developed using gene-editing for agrigenomics.
Premium access

Detailed competitors of Channel Bio

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Channel Bio

Websites that share an audience with Channel Bio (channel.com).

Similar websites

Websites whose visitors overlap most with Channel Bio. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
lgseeds.com
lgseeds.com
100%
#4,230,996–
roundupreadyplus.com
roundupreadyplus.com
87%
–
agrigold.com
86%
680.7K#3,564,013View details
mycogen.com
83%
View details
beckshybrids.com
beckshybrids.com
81%
#201,906–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 18 similar websites and full traffic analytics for Channel Bio

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 18 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Channel Bio (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Channel Bio

Premium access

Complete news archive for Channel Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Channel Bio

Channel Bio was founded in 2009.

Channel Bio is headquartered in Kentland, United States. It is registered at Kentland, Indiana, United States.

Channel Bio Corp. is a fully owned subsidiary of the Monsanto Co which acquired it in Nov, 2004. It engages in field trials for new seed genetics, commercial production and marketing of genetically modified (GM) field crops including corn, soy, sorghum and alfalfa. Focuses on traits for improving yield and increasing tolerance to abiotic stresses. Has research partnerships with Monsanto for acquiring crop traits. The company has a network of sales agents who directly sell to the farmer; also sells through conventional resellers. It also provides seedsman services for identifying genetics suitable to farmers existing infrastructure and operations.

Channel Bio's top competitors include Benson Hill, Cibus and Pairwise.

Channel Bio offers Corn Seed, Soybean Seed, and Agronomy Tools.

Channel Bio has 1 investor. Key investors include Monsanto.

Yes. Channel Bio was acquired by Monsanto in November 2004.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available